Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Jakob Schöllhammer Knudsen; Reimar Wernich Thomsen; Anton Pottegård; Filip Krag Knop; Henrik Toft Sørensen

doi:10.2337/dc18-0999

Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Jakob Schöllhammer Knudsen, Reimar Wernich Thomsen, Anton Pottegård, Filip Krag Knop, Henrik Toft Sørensen

Institut for Klinisk Medicin

10 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Diabetes Care
Vol/bind	41
Udgave nummer	9
Sider (fra-til)	e133-e135
Antal sider	3
ISSN	0149-5992
DOI	https://doi.org/10.2337/dc18-0999
Status	Udgivet - 1 sep. 2018

Adgang til dokumentet

10.2337/dc18-0999

e133.full.pdfForlagets udgivne version, 529 KB

https://care.diabetesjournals.org/content/diacare/41/9/e133.full.pdf

Citationsformater

@article{32ee3ca4e5b14b8c9e7174e75eac6621,

title = "Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide",

author = "Knudsen, {Jakob Sch{\"o}llhammer} and Thomsen, {Reimar Wernich} and Anton Potteg{\aa}rd and Knop, {Filip Krag} and S{\o}rensen, {Henrik Toft}",

year = "2018",

month = sep,

day = "1",

doi = "10.2337/dc18-0999",

language = "English",

volume = "41",

pages = "e133--e135",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association",

number = "9",

}

TY - JOUR

T1 - Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

AU - Knudsen, Jakob Schöllhammer

AU - Thomsen, Reimar Wernich

AU - Pottegård, Anton

AU - Knop, Filip Krag

AU - Sørensen, Henrik Toft

PY - 2018/9/1

Y1 - 2018/9/1

U2 - 10.2337/dc18-0999

DO - 10.2337/dc18-0999

M3 - Letter

C2 - 30002200

SN - 0149-5992

VL - 41

SP - e133-e135

JO - Diabetes Care

JF - Diabetes Care

IS - 9

ER -